Frequently Asked Questions
Common Questions About Using ICD-10 Code G21.0 for Malignant neuroleptic syndrome
What are the common causes of Malignant neuroleptic syndrome?
Malignant neuroleptic syndrome is primarily caused by the use of antipsychotic medications, particularly first-generation agents. Rapid dose escalation or changes in medication can also trigger this syndrome.
How is Malignant neuroleptic syndrome treated?
Treatment involves immediate discontinuation of antipsychotic medications, supportive care including hydration and cooling measures, and monitoring for complications. Hospitalization is often required for severe cases.
Is Malignant neuroleptic syndrome contagious?
No, Malignant neuroleptic syndrome is not contagious. It is a reaction to medication and does not spread from person to person.
What is the prognosis for patients with Malignant neuroleptic syndrome?
With prompt recognition and treatment, the prognosis for patients with Malignant neuroleptic syndrome can be favorable. However, delays in treatment can lead to serious complications or death.
